NFKB1 and cancer: A number of EGFR signaling pathways have been linked to NFκB activation downstream of ligand stimulation or constitutive EGFR activation in cancer cells, primarily by promoting degradation of IκB proteins that sequester inactive NFκB proteins in the cytoplasm [79,111].